Cargando…

Calcineurin/CXCR4 in T-ALL

Detalles Bibliográficos
Autores principales:	Passaro, Diana, Quang, Christine Tran, Ghysdael, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671917/ https://www.ncbi.nlm.nih.gov/pubmed/26682242

Ejemplares similares

A TCR-switchable cell death pathway in T-ALL
por: Quang, Christine Tran, et al.
Publicado: (2017)

The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells
por: Tran Quang, C, et al.
Publicado: (2015)

NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia
por: Catherinet, Claire, et al.
Publicado: (2021)

Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020)

The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis
por: Hawkins, Oriana E, et al.
Publicado: (2012)

CXCR4 antagonists for treatment of breast cancer
por: Cortés, Javier, et al.
Publicado: (2018)

EPI-X4, a novel endogenous antagonist of CXCR4
por: Buske, Christian, et al.
Publicado: (2015)

CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017)

Topical Calcineurin Inhibitors: Expanding Indications for Corneal and Ocular Surface Inflammation
por: Ghasemi, Hamed, et al.
Publicado: (2019)

CXCR4 antagonists in hematologic malignancies: more than just mobilizers?
por: Jo, Deog-Yeon
Publicado: (2011)

Calcineurin
por: Creamer, Trevor P.
Publicado: (2020)

CXCR4 Chemokine Receptor Overview: Biology, Pathology and Applications in Imaging and Therapy
por: Jacobson, Orit, et al.
Publicado: (2013)

Calcineurin Inhibitors in Lung Donors to Attenuate Ischemia–Reperfusion Injury in Recipients: Next Steps?
por: Rozenberg, Dmitry, et al.
Publicado: (2022)

Phagocytosis of Particulate Antigens – All Roads Lead to Calcineurin/NFAT Signaling Pathway
por: Fric, Jan, et al.
Publicado: (2014)

Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
por: Smith, Charlotte, et al.
Publicado: (2023)

ISG15 Modulates Development of the Erythroid Lineage
por: Maragno, Ana Leticia, et al.
Publicado: (2011)

Characterization of calcineurin from Cryptococcus humicola and the application of calcineurin in aluminum tolerance
por: Zhang, Lei, et al.
Publicado: (2017)

Calcineurin in development and disease
por: Chen, Lei, et al.
Publicado: (2021)

Development and Evaluation of an (18)F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression
por: Brickute, Diana, et al.
Publicado: (2019)

All hail reproducibility in microbiome research
por: Ravel, Jacques, et al.
Publicado: (2014)

Balanced interactions of calcineurin with AKAP79 regulate Ca(2+)–calcineurin–NFAT signaling
por: Li, Huiming, et al.
Publicado: (2012)

A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway in vivo and in vitro
por: Wang, Ping, et al.
Publicado: (2021)

Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
por: Rafael-Vidal, Carlos, et al.
Publicado: (2021)

Calcineurin regulates aldosterone production via dephosphorylation of NFATC4
por: Berber, Mesut, et al.
Publicado: (2023)

Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death
por: Tosello, Valeria, et al.
Publicado: (2016)

Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?
por: Beckebaum, Susanne, et al.
Publicado: (2010)

Calcineurin in a Crowded World
por: Cook, Erik C., et al.
Publicado: (2016)

Calcineurin, Synaptic Plasticity, and Memory
por: Weitlauf, Carl, et al.
Publicado: (2001)

Transient disorder: Calcineurin as an example
por: Creamer, Trevor P
Publicado: (2013)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Calcineurin Inhibitors in Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney
por: Descazeaud, Virginie, et al.
Publicado: (2012)

Will the Stroma-derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer?
por: Kim, Hungdai
Publicado: (2012)

Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis
por: Hernandez, Lorena, et al.
Publicado: (2011)

Correlation of CXCR4/CXCR7 signaling pathway with pre-eclampsia
por: Zheng, Zhi, et al.
Publicado: (2018)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL
por: Sison, Edward Allan R., et al.
Publicado: (2015)

Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia
por: Kaiser, Lisa Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ffchv6q05lnc2sc20in9l8idb7